Skip to content
value.today

Windgap Medical, Inc.

🇺🇸 Somerville, Massachusetts, USAPharmaceuticalsFounded 2011
Total raised
$76 M
7 rounds on record
Latest round
$13 M
Nov 2023
First round on record
Apr 2014
Today
Private
No later event on record

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Windgap Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2023$13 MNo. 7$10 to $50 million

Windgap Medical, Inc.: Raise no. 7, Nov 2023

Investors in this round

13 investors had bought by the notice of Jan 26, 2026: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $17 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Aaron Reading Mann · Executive Officer, Director
  • Anthony Reading Watson · Executive Officer
  • Jason Reading Durkin · Executive Officer
  • John Reading Cadigan · Executive Officer
  • Max Reading Meehan · Executive Officer
  • Brent Reading Buchine · Director
  • John Reading Wilson · Director
  • Richard Russell · Director
  • Timothy Reading Krochuk · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Aaron Mann, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jan 26, 2026. Read the notice at the SEC.

debt, optionsSEC
Aug 2021$39 MNo. 6$10 to $50 million

Windgap Medical, Inc.: Raise no. 6, Aug 2021

Investors in this round

46 investors had bought by the notice of Jan 25, 2022: 46 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$39 M of $42 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brent Buchine · Executive Officer, Director
  • Christopher Stepanian · Executive Officer, Director
  • John Conley · Director
  • John Reading Wilson · Director
  • Michael Reading Huang · Director
  • Richard Reading Russell · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christopher Stepanian, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Jan 25, 2022. Read the notice at the SEC.

equitySEC
Jan 2019$12 MNo. 5$10 to $50 million

Windgap Medical, Inc.: Raise no. 5, Jan 2019

Investors in this round

106 investors had bought by the notice of Jan 17, 2019: 106 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $39 M offered; $27 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brent Buchine · Executive Officer, Director
  • Christopher Stepanian · Executive Officer, Director
  • J. Melville Engle · Director
  • John Melville Conley · Director
  • John Reading Wilson · Director
  • Richard Melville Gabriel · Director
  • Tim Melville Krochuk · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christopher Stepanian, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 17, 2019. Read the notice at the SEC.

equitySEC
May 2017$4 MNo. 4$2 to $10 million

Windgap Medical, Inc.: Raise no. 4, May 2017

Investors in this round

75 investors had bought by the notice of Jul 9, 2018: 75 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brent Buchine · Executive Officer, Director
  • Christopher Stepanian · Executive Officer, Director
  • J. Melville Engle · Director
  • John Melville Conley · Director
  • Richard Melville Gabriel · Director
  • Tim Melville Krochuk · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christopher Stepanian, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 9, 2018. Read the notice at the SEC.

debt, optionsSEC
Mar 2016$3 MNo. 3$2 to $10 million

Windgap Medical, Inc.: Raise no. 3, Mar 2016

Investors in this round

46 investors had bought by the notice of Apr 8, 2016: 46 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brent Buchine · Executive Officer, Director
  • Christopher Stepanian · Executive Officer, Director
  • J. Melville Engle · Director
  • John Melville Conley · Director
  • Richard Melville Gabriel · Director
  • Tim Melville Krochuk · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christopher Stepanian, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 8, 2016. Read the notice at the SEC.

debt, optionsSEC
May 2015$4 MNo. 2$2 to $10 million

Windgap Medical, Inc.: Raise no. 2, May 2015

Investors in this round

92 investors had bought by the notice of Aug 24, 2015: 92 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $0 M still to sell
Smallest investment taken
$4,200
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$465,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brent Buchine · Executive Officer, Director
  • Christopher Stepanian · Executive Officer, Director
  • Tim Melville Krochuk · Executive Officer
  • J. Melville Engle · Director
  • John Melville Conley · Director
  • Richard Melville Gabriel · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The issuer expects to pay approximately $465,000 of the gross proceeds to related persons as compensation, including the provision of benefits, over the course of eighteen (18) months.”

Signed by Christopher Stepanian, President and Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Aug 24, 2015. Read the notice at the SEC.

equitySEC
Apr 2014$1 MNo. 1Under $2 million

Windgap Medical, Inc.: Raise no. 1, Apr 2014

Investors in this round

56 investors had bought by the notice of Apr 24, 2014: 56 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $1 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$362,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brent Buchine · Executive Officer, Director
  • Christopher Stepanian · Executive Officer, Director
  • J. Melville Engle · Director
  • John Melville Conley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The issuer expects to pay approximately $362,000 of the gross proceeds to related persons as compensation, including the provision of benefits.”

Signed by Christopher Stepanian, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 24, 2014. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Windgap Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2026).

    SEC Form D · Jan 2026

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Jan 2026

That is all the official record says: Windgap Medical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Windgap Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 106 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Windgap Medical, Inc.
NameRoleNamed in
Aaron Reading MannExecutive officerJan 2026
Anthony Reading WatsonExecutive officerJan 2026
Jason Reading DurkinExecutive officerJan 2026
John Reading CadiganExecutive officerJan 2026
Max Reading MeehanExecutive officerJan 2026
Brent Reading BuchineExecutive officerNov 2023
Michael Reading SamarExecutive officerNov 2023
Brent BuchineExecutive officerJan 2022
Christopher StepanianExecutive officerJan 2022
Tim Melville KrochukExecutive officerAug 2015
Aaron Reading MannDirectorJan 2026
Brent Reading BuchineDirectorJan 2026
John Reading WilsonDirectorJan 2026
Richard RussellDirectorJan 2026
Timothy Reading KrochukDirectorJan 2026
John ConleyDirectorNov 2023
Michael Reading HuangDirectorNov 2023
William Reading McKeeDirectorNov 2023
Brent BuchineDirectorJan 2022
Christopher StepanianDirectorJan 2022
Richard Reading RussellDirectorJan 2022
J. Melville EngleDirectorJan 2019
John Melville ConleyDirectorJan 2019
Richard Melville GabrielDirectorJan 2019
Tim Melville KrochukDirectorJan 2019